(Q43796150)

26 November 2017

title

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus (English)

1 reference

26 November 2017

0 references

1 reference

26 November 2017

G M Reaven

1 reference

26 November 2017

F Abbasi

1 reference

26 November 2017

T Asagmi

1 reference

26 November 2017

C Lamendola

1 reference

26 November 2017

T McLaughlin

1 reference

26 November 2017

M Stuehlinger

1 reference

26 November 2017

P S Tsao

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Cardiology

26 November 2017

published in

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

1201-1203

1 reference

Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Does ADMA cause endothelial dysfunction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902063-X

10.1016/S0002-9149(01)02063-X

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference